Dorsey Griffith, UC Davis
A major new study from the UC Davis Alzheimer’s Center has uncovered dramatic differences in the brains of Hispanics with a dementia diagnosis compared with those of non-Hispanic whites and of African Americans.
The first-of-its-kind study, based on extensive analyses of autopsied brains, found that Hispanics diagnosed with dementia were much more likely to have cerebrovascular disease than either non-Hispanic whites or African Americans. Researchers also found that Hispanics and African Americans were more likely to have mixed pathologies, that is, a combination of Alzheimer’s disease and cerebrovascular disease, than non-Hispanic whites. And non-Hispanic whites were shown to have more pure Alzheimer’s disease than either Hispanics or African Americans.
Published today in the Journal of Alzheimer’s Disease, the findings may help explain the higher rates of dementia among blacks and Hispanics, and point to the importance of treating each patient based on their individual risk factors.
Vascular disease treatment urged for all groups
“If you are Latino and diabetic or black and hypertensive, you are probably at higher risk for dementia and these risks should be addressed aggressively,” said Charles DeCarli, director of the Alzheimer’s Disease Center and principal investigator on the study. “It’s a way to tailor our approach to the individual, and it’s something we want to do as early as possible.”
DeCarli, recognizing a need to broaden the range of individuals being evaluated by physicians for dementia, began the research 15 years ago. He said because most of the people who have historically sought help for memory problems were non-Hispanic whites, any research based on this population carries implicit bias.
“Our idea was to move from just a clinic-based referral system to then create a community-based recruitment system, where we could broaden the range of people who are being evaluated and include those who have very low socio-economic status and low education.”
DeCarli and his colleagues had two hypotheses; first, that they would find some common biological pathways among people with dementia, and second that there may be differences that are meaningful and remediable.
“There is fairly decent evidence today that there are similarities and differences, and that it’s never good to have the brain shrink, particularly around the temporal lobe, but the cause of this dementia seems different depending on whether you’re white, black or Latino,” he said. “These differences can be due to numerous factors including cultural, social, economic, and/or behavioral influences.”
Donated brains key to dementia research
For this study, researchers analyzed brain tissue from 423 people who had died after a dementia diagnosis. All of the individuals, who had agreed previously to donate their brains for dementia research, had been seen at one of the two UC Davis Alzheimer’s Disease Center clinics. Among them were 360 non-Hispanic whites, 35 blacks and 28 Hispanics. All of the participants were assessed annually prior to their deaths, receiving physical and neurological exams, and giving detailed health histories.
The brains included in the study were from decedents who had autopsies between Jan. 1, 2000 and Jan. 14, 2017.
Studies of each brain specimen involve a complex and lengthy process of dissection, tissue staining, processing, analysis, synthesis, diagnoses and cataloging, said neuropathologist Brittany Dugger, assistant professor in the Department of Pathology and Laboratory Medicine and corresponding author on the paper.
Dugger and her colleagues looked at different regions of the brain such as the frontal cortex, hippocampus and cerebellum for amyloid plaques, which are markers of Alzheimer’s disease, and appear as sunbursts outside of the cell. They also looked for neurofibrillary tangles inside the cell that appear under the microscope as tiny balls of “tangled” hair, and that can also indicate Alzheimer’s disease. To tease out cerebrovascular disease, they used special stains that reveal infarctions to the trained eye, the pathologic manifestations of a stroke.
They found a mixed diagnosis of dementia — both Alzheimer’s disease and cerebrovascular disease — in 37 percent of non-Hispanic whites and 37 percent of blacks, but 54 percent of Hispanics. By the same token, only 4 percent of non-Hispanic whites had only cerebrovascular disease compared with 11 percent of blacks and 21 percent of Hispanics. And pure Alzheimer’s disease (without cerebrovascular disease) was found in 43 percent of non-Hispanic whites and 43 percent of blacks, but only 14 percent of Hispanics.
DeCarli cautioned that the study is relatively small and is limited because almost all of the participants came into the clinic with memory loss, so the results cannot be extrapolated more broadly in these populations.
Vascular disease may account for higher rates of dementia
“But it looked very clear to us that vascular disease plays a much stronger role in the Latino population, and is a contributing factor in the black population and that it may account for an overall higher incidence of dementia in these groups.”
DeCarli said the research team now plans to gather additional data from community-based studies, as well as autopsy data to more realistically reflect the role of mixed pathologies in the brain across diverse populations.
This study was funded by an NIH grant, P30 AG010129.
Other UC Davis authors include Lee-Way Jin, John M. Olichney, Sarah T. Farias, Luis Carvajal-Carmona, Paul Lott, Dan Mungas and Laurel A. Beckett. Teresa Jenica Filshtein at UCSF and Bruce Reed of the Division of Neuroscience, Development and Aging at the NIH also contributed.
The UC Davis Alzheimer's Disease Center is one of only 27 research centers designated by the National Institutes of Health's National Institute on Aging. The center's goal is to translate research advances into improved diagnosis and treatment for patients while focusing on the long-term goal of finding a way to prevent or cure Alzheimer's disease. Also funded by the state of California, the center allows researchers to study the effects of the disease on a uniquely diverse population. For more information, visit alzheimer.ucdavis.edu.